Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 07/30/14 → 07/21/16 |
Funding
- Auxilium Pharmaceuticals: $4,000.00
A Phase 2a, Double-Blind, Randomized, Placebo-Controlled, Dose-Ranging Study to Evaluate the Safety and Effectiveness of AA4500 in the Treatment of Dupuytren's Disease Nodules
- Hurst, Lawrence (PI)
- Badalamente, Marie (CoPI)
- Muhlrad, Samantha (CoPI)
- Gelfand, Mark (CoPI)
- Kolanko, Nicholas (CoPI)
Project: Research